U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090525) titled 'Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions' on July 16.
Brief Summary: The purpose of this study is to explore the efficacy and safety ofof bevacizumab plus cisplatin compare with cisplatin in the treatment of malignant serous effusion in patients with advanced adenocarcinoma
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Overall Response Rate
Intervention:
DRUG: Intracavity injection of bevacizumab 7.5mg/kg plus cisplatin 40mg/m2
Intracavity injection of bevacizumab 7.5mg/kg plus cisplatin 40mg/m2, repeat use on 21st day if the serous effusion not controlle...